Whats happening at Human Genome Sciences, Inc.?
Human Genome Sciences (HGSI) is an emerging biotech company that announced promising results in one of its study drugs, BENLYSTA TM, designed for use in patients with lupus. Lupus is a painful disease in which the body attacks its own tissues. The drug is set for further study trials that are expected to confirm the results of the July findings by November. The drug will then move on for FDA approval and would be the first new pharmaceutical for lupus in 50 years.
Related Questions
- Is it fair to say that, as a human, you enjoy the chaos and beauty of wilderness and nature, but not enough to prefer it over right angles, sterilized order, pathological security and rigorous predictability?
- How did former Human Genome Sciences CEO Bill Haseltine [Chairman of the Board] get involved?
- Francis, what is the human genome?
